Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Colorcon
Dow
Merck
AstraZeneca

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Litigation Details for Roxane Laboratories, Inc. v. Abbott Laboratories (S.D. Ohio )

See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Roxane Laboratories, Inc. v. Abbott Laboratories
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Roxane Laboratories, Inc. v. Abbott Laboratories (S.D. Ohio )

Date Filed Document No. Description Snippet Link To Document
2013-04-30 100 connection with Patent Nos. 7,148,359 (the “’359 patent”) and 7,364,752 (the “’752 patent”) held by defendants…Norvir®, “before the expiration of the Listed Patents.” Amended Complaint, ¶ 16. Plaintiff…that the asserted claims of the ’359 and ’752 patents are obvious over certain prior art references. …have responded by asserting counterclaims for patent infringement, alleging that plaintiff’s ANDA … filing infringed the ’359 and ’752 patents under 35 U.S.C. § 271(e)(2)(A). Defendants’ Answer, External link to document
2013-09-03 128 infringed Abbott’s ‘359 patent, ‘752 patent, and Patent Nos. 5,648,497 (the “̔497 patent”), 6,037,157 (the…connection with Patent Nos. 7,148,359 (the “̔359 patent”) and 7,364,752 (the “̔752 patent”) held by defendants…the “̔157 patent”), and 6,703,403 B2 (the “̔403 patent”), all related to the drug Norvir®. 2:13-cv-… ̔359 and ̔752 patents, which are referred to in the interrogatories as the “Patents- in-Suit.” …” the ʽ497, ̔157, and ̔403 patents (collectively the “transferred patents”). Id. at Exhibit 7, External link to document
2013-09-16 129 Abbott’s ‘359 patent, ‘752 patent, and Patent Nos. 5,648,497 (the “̔497 patent”), 6,037,157…connection with Patent Nos. 7,148,359 (the “̔359 patent”) and 7,364,752 (the “̔752 patent”) held by …was issued patent Nos. 8,268,349 B2 (the “’349 patent”) and 8,399,015 B2 (the “’015 patent”) on September…6,037,157 (the “̔157 patent”), and 6,703,403 B2 (the “̔403 patent”), all related to the drug…Similarly, all the patents at issue relate to Norvir®, and both actions involve patents directed to aspects External link to document
2013-03-28 91 briefs. The Figures in United States Patent No. 7,148,359 referred to in plaintiff’s new construction… is GRANTED. I. Background This is a patent infringement action in which plaintiff Roxane …Inc., seeks a declaration of noninfringement of patents currently held by defendant AbbVie Inc., relating…glass transition as shown in Figure 10 of the ‘359 patent) that is also characterized by the lack of crystal…structure (i.e., as shown in Figure 3 of the ‘359 patent).” Plaintiff’s Motion, Exhibit C. Defendants External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Mallinckrodt
McKinsey
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.